Currently, Lopez is the chief operating officer of Fero and the managing director of Pharmaroth Latin America.
Lopez will be responsible for developing and executing the company’s global business development strategy in addition to his current operational responsibilities related to all aspects of Sucanon production, sales, marketing, and distribution.
Fero president and COO Lopez said the successful launch and marketing of Sucanon in Mexico and continued positive patient feedback affirms that both Fero and Sucanon are well-positioned to quickly expand on a global scale to improve the lives of millions of type-2 diabetes sufferers worldwide.